Information about B.C. Oncology
My details
*
*
*

B.C. Oncology (SA)

Company information

Status
Active

Enterprise number

BE0629.859.206

VAT liability
No
Established
07-05-2015
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from B.C. Oncology

2024 2023 2022 2021
Profit/Loss -5,208 2 % -5,301 3 % -5,442 -4 % -5,228
Equity 9,487,424 0 % 9,492,632 0 % 9,497,933 0 % 9,503,375
Gross margin -3,701 10 % -4,110 7 % -4,424 -5 % -4,217

Publications from B.C. Oncology

Date Publication
20-07-2022 Registered Office (NL)
02-03-2022 Resignations - Appointments (NL)
27-10-2021 Resignations - Appointments (NL)
26-02-2020 Resignations - Appointments (NL)
19-11-2019 Resignations - Appointments (NL)

Frequently asked questions

What is the enterprise number of B.C. Oncology?
The enterprise number of B.C. Oncology is BE 0629.859.206.
Wat is the PEPPOL ID of B.C. Oncology?
There is no information available about the PEPPOL ID of B.C. Oncology or the company is not yet registered on the PEPPOL network.
When was B.C. Oncology founded?
B.C. Oncology was founded on 07-05-2015.
What is the address of B.C. Oncology?
The current registered office of B.C. Oncology is located at Da Vincilaan 1, 1930 Zaventem.
When was the last time B.C. Oncology filed their annual financial statements?
The most recent financial statements of B.C. Oncology were filed on 04-07-2025.
How many employees does B.C. Oncology have?
There are currently no employees working at B.C. Oncology or no workforce information is available.
What is the annual turnover of B.C. Oncology?
At the time of its most recent financial statements, B.C. Oncology did not publish any turnover figures. B.C. Oncology reported a gross margin of -€3,700.87.